289 related articles for article (PubMed ID: 18573897)
21. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
22. Characterization of novel multiantigenic vaccine candidates with pan-HLA coverage against Mycobacterium tuberculosis.
Kovjazin R; Shitrit D; Preiss R; Haim I; Triezer L; Fuks L; Nader AR; Raz M; Bardenstein R; Horn G; Smorodinsky NI; Carmon L
Clin Vaccine Immunol; 2013 Mar; 20(3):328-40. PubMed ID: 23283639
[TBL] [Abstract][Full Text] [Related]
23. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
[TBL] [Abstract][Full Text] [Related]
24. [Identification and evaluation of T cell epitopes of Rv0585c from
Wang XX; Chen X; Li YQ; Xiao TY; Jiang Y; Li MC; Liu HC; Wan KL
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):665-669. PubMed ID: 28651408
[No Abstract] [Full Text] [Related]
25. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.
Peña D; Rovetta AI; Hernández Del Pino RE; Amiano NO; Pasquinelli V; Pellegrini JM; Tateosian NL; Rolandelli A; Gutierrez M; Musella RM; Palmero DJ; Gherardi MM; Iovanna J; Chuluyan HE; García VE
EBioMedicine; 2015 Aug; 2(8):884-90. PubMed ID: 26425695
[TBL] [Abstract][Full Text] [Related]
26. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis.
Mustafa AS; Amoudy HA; Wiker HG; Abal AT; Ravn P; Oftung F; Andersen P
Scand J Immunol; 1998 Nov; 48(5):535-43. PubMed ID: 9822264
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis antigen-induced expression of IFN-α in tuberculosis patients inhibits production of IL-1β.
Ma J; Yang B; Yu S; Zhang Y; Zhang X; Lao S; Chen X; Li B; Wu C
FASEB J; 2014 Jul; 28(7):3238-48. PubMed ID: 24675363
[TBL] [Abstract][Full Text] [Related]
28. The immune characterization of interferon-β responses in tuberculosis patients.
Zhang X; Sun Y; He C; Qiu X; Zhou D; Ye Z; Long Y; Tang T; Su X; Ma J
Microbiol Immunol; 2018 Apr; 62(4):281-290. PubMed ID: 29504148
[TBL] [Abstract][Full Text] [Related]
29. Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70.
Al-Attiyah R; Shaban FA; Wiker HG; Oftung F; Mustafa AS
Infect Immun; 2003 Apr; 71(4):1953-60. PubMed ID: 12654813
[TBL] [Abstract][Full Text] [Related]
30. Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.
Blanco FC; Bianco MV; Garbaccio S; Meikle V; Gravisaco MJ; Montenegro V; Alfonseca E; Singh M; Barandiaran S; Canal A; Vagnoni L; Buddle BM; Bigi F; Cataldi A
Tuberculosis (Edinb); 2013 May; 93(3):363-72. PubMed ID: 23518075
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis.
Coler RN; Skeiky YA; Vedvick T; Bement T; Ovendale P; Campos-Neto A; Alderson MR; Reed SG
J Immunol; 1998 Sep; 161(5):2356-64. PubMed ID: 9725231
[TBL] [Abstract][Full Text] [Related]
32. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
[TBL] [Abstract][Full Text] [Related]
33. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics.
Cockle PJ; Gordon SV; Lalvani A; Buddle BM; Hewinson RG; Vordermeier HM
Infect Immun; 2002 Dec; 70(12):6996-7003. PubMed ID: 12438379
[TBL] [Abstract][Full Text] [Related]
36. In vitro levels of cytokines in response to purified protein derivative (PPD) antigen in a population with high prevalence of pulmonary tuberculosis.
Giampietro F; de Waard JH; Rivas-Santiago B; Enciso-Moreno JA; Salgado A; Araujo Z
Hum Immunol; 2010 Nov; 71(11):1099-104. PubMed ID: 20650294
[TBL] [Abstract][Full Text] [Related]
37. The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis.
Lee JS; Song CH; Lim JH; Kim HJ; Park JK; Paik TH; Kim CH; Kong SJ; Shon MH; Jung SS; Jo EK
Clin Exp Immunol; 2003 Jun; 132(3):443-9. PubMed ID: 12780691
[TBL] [Abstract][Full Text] [Related]
38. Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosis.
Agger EM; Brock I; Okkels LM; Arend SM; Aagaard CS; Weldingh KN; Andersen P
Immunology; 2003 Dec; 110(4):507-12. PubMed ID: 14632649
[TBL] [Abstract][Full Text] [Related]
39. Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis.
Kassa D; Ran L; Geberemeskel W; Tebeje M; Alemu A; Selase A; Tegbaru B; Franken KL; Friggen AH; van Meijgaarden KE; Ottenhoff TH; Wolday D; Messele T; van Baarle D
Clin Vaccine Immunol; 2012 Dec; 19(12):1907-15. PubMed ID: 23015647
[TBL] [Abstract][Full Text] [Related]
40. Enhanced T cell responsiveness to Mycobacterium bovis BCG r32-kDa Ag correlates with successful anti-tuberculosis treatment in humans.
Sai Priya VH; Latha GS; Hasnain SE; Murthy KJ; Valluri VL
Cytokine; 2010 Dec; 52(3):190-3. PubMed ID: 20797873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
